Soft tissue sarcomas: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

被引：80

作者：

Casali, P. G. ^{[1
]}

Jost, L. ^{[2
]}

Sleijfer, S. ^{[3
]}

Verweij, J. ^{[3
]}

Blay, J. -Y. ^{[4
]}

机构：

[1] Ist Nazl Tumori, Dept Canc Med, I-20133 Milan, Italy

[2] Kantonsspital, Dept Oncol, Bruderholz, Switzerland

[3] Erasmus Univ, Med Ctr, Dept Med Oncol, Rotterdam, Netherlands

[4] Univ Lyon 1, U590, INSERM, F-69365 Lyon, France

来源：

ANNALS OF ONCOLOGY | 2008年 / 19卷

关键词：

D O I：

10.1093/annonc/mdn101

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：89 / 93

页数：5

共 16 条

[1] AN INTERGROUP PHASE-III RANDOMIZED STUDY OF DOXORUBICIN AND DACARBAZINE WITH OR WITHOUT IFOSFAMIDE AND MESNA IN ADVANCED SOFT-TISSUE AND BONE SARCOMAS [J].

ANTMAN, K ;

CROWLEY, J ;

BALCERZAK, SP ;

RIVKIN, SE ;

WEISS, GR ;

ELIAS, A ;

NATALE, RB ;

COOPER, RM ;

BARLOGIE, B ;

TRUMP, DL ;

DOROSHOW, JH ;

AISNER, J ;

PUGH, RP ;

WEISS, RB ;

COOPER, BA ;

CLAMOND, GH ;

BAKER, LH .

JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (07) :1276-1285

[2]

Eggermont Alexander M, 2003, Surg Oncol Clin N Am, V12, P469, DOI 10.1016/S1055-3207(03)00012-7

[3]

Fata F, 1999, CANCER-AM CANCER SOC, V86, P2034, DOI 10.1002/(SICI)1097-0142(19991115)86:10<2034::AID-CNCR21>3.3.CO

[4]

2-G

[5] Phase II and pharmacokinetic study of ecteinascidin 743 in patients with progressive sarcomas of soft tissues refractory to chemotherapy [J].

Garcia-Carbonero, R ;

Supko, JG ;

Manola, J ;

Seiden, MV ;

Harmon, D ;

Ryan, DP ;

Quigley, MT ;

Merriam, P ;

Canniff, J ;

Goss, G ;

Matulonis, U ;

Maki, RG ;

Lopez, T ;

Puchalski, TA ;

Sancho, MA ;

Gomez, J ;

Guzman, C ;

Jimeno, J ;

Demetri, GD .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (08) :1480-1490

[6] Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study [J].

Grosso, Federica ;

Jones, Robin L. ;

Demetri, George D. ;

Judson, Ian R. ;

Blay, Jean-Yves ;

Le Cesne, Axel ;

Sanfilippo, Roberta ;

Casieri, Paola ;

Collini, Paola ;

Dileo, Palma ;

Spreafico, Carlo ;

Stacchiotti, Silvia ;

Tamborini, Elena ;

Tercero, Juan Carlos ;

Jimeno, Jose ;

D'Incalci, Maurizio ;

Gronchi, Alessandro ;

Fletcher, Jonathan A. ;

Pilotti, Silvana ;

Casali, Paola G. .

LANCET ONCOLOGY, 2007, 8 (07) :595-602

[7] Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: Results of a phase II trial [J].

Hensley, ML ;

Maki, R ;

Venkatraman, E ;

Geller, G ;

Lovegren, M ;

Aghajanian, C ;

Sabbatini, P ;

Tong, W ;

Barakat, R ;

Spriggs, DR .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (12) :2824-2831

[8]

Issels RD, 2007, J CLIN ONCOL, V25

[9] The pharmacological treatment of aggressive fibromatosis: a systematic review [J].

Janinis, J ;

Patriki, M ;

Vini, L ;

Aravantinos, G ;

Whelan, JS .

ANNALS OF ONCOLOGY, 2003, 14 (02) :181-190

[10] Systemic therapy for advanced uterine sarcoma: A systematic review of the literature [J].

Kanjeekal, S ;

Chambers, A ;

Fung, MFK ;

Verma, S .

GYNECOLOGIC ONCOLOGY, 2005, 97 (02) :624-637

← 1 2 →